Table 2.
Characteristic | PD-L1 expression | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
TC | IC | |||||||||
Negative (n, %) |
Any+ (n, %) |
P value | Negative (n, %) |
Any+ (n, %) |
P value | |||||
Age (years) | 0.380 | 0.719 | ||||||||
<58 | 43 | 67% | 21 | 33% | 40 | 63% | 24 | 38% | ||
≥58 | 43 | 60% | 29 | 40% | 48 | 67% | 24 | 33% | ||
Sex | <0.001 | 0.854 | ||||||||
Male | 45 | 52% | 41 | 48% | 55 | 64% | 31 | 36% | ||
Female | 41 | 82% | 9 | 18% | 33 | 66% | 17 | 34% | ||
Smoking status | 0.186 | 0.508 | ||||||||
Never smoker | 72 | 66% | 37 | 34% | 72 | 66% | 37 | 34% | ||
Smoker | 14 | 52% | 13 | 48% | 16 | 59% | 11 | 41% | ||
Pathologic stage | 0.586 | 0.098 | ||||||||
IIIB | 36 | 67% | 18 | 33% | 30 | 56% | 24 | 44% | ||
IV | 50 | 61% | 32 | 39% | 58 | 71% | 24 | 29% | ||
Mutation status | 0.049 | 0.475 | ||||||||
EGFR mutant | 43 | 74% | 15 | 26% | 38 | 66% | 20 | 34% | ||
KRAS mutant | 11 | 65% | 6 | 35% | 13 | 76% | 4 | 24% | ||
Other | 32 | 52% | 29 | 48% | 37 | 61% | 24 | 39% |